In our study, we showed that EYA2 was associated with CSCs markers YBX1, KLF5, and SOX10 in breast tumor tissues, and EYA2 overexpression up-regulated YBX1 in breast cancer cell lines. This evidence concerns the gene YBX1 and breast carcinoma.